Login / Signup
Duration of trastuzumab in HER2-positive metastatic breast cancer after complete remission: still debatable issue?
Kadri Altundag
Published in:
Breast cancer research and treatment (2017)
Keyphrases
</>
metastatic breast cancer
disease activity
ulcerative colitis
systemic lupus erythematosus